Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
While applying prospective DPYD genotyping to clinical practice has successfully reduced the incidence of severe toxicity, a substantial number of patients treated with fluoropyrimidines still experience severe treatment-related toxicity [5]. We hypothesized that in addition to the four established DPYD variants, other genetic variations in- and outside DPYD might be associated with the onset of severe fluoropyrimidine-related toxicity.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
